Shares of Evoke plc (LON:EVOK – Get Free Report) traded down 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). 65,066,164 shares traded hands during trading, an increase of 1,994% from the average session volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Wall Street Analyst Weigh In
EVOK has been the topic of a number of research analyst reports. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 140 ($1.81) target price on shares of Evoke in a report on Monday, December 16th. Berenberg Bank reduced their price objective on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating on the stock in a research note on Wednesday, December 4th.
Get Our Latest Research Report on EVOK
Evoke Stock Performance
Evoke (LON:EVOK – Get Free Report) last issued its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. As a group, sell-side analysts expect that Evoke plc will post 12.7648305 earnings per share for the current year.
Insider Transactions at Evoke
In other Evoke news, insider Andrea Gisle Joosen purchased 14,572 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were bought at an average price of GBX 70 ($0.91) per share, with a total value of £10,200.40 ($13,202.69). Insiders own 27.00% of the company’s stock.
About Evoke
Read More
- Five stocks we like better than Evoke
- How to Use Stock Screeners to Find Stocks
- MarketBeat Week in Review – 03/24 – 03/28
- Dividend Capture Strategy: What You Need to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Pros And Cons Of Monthly Dividend Stocks
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.